PCK 3.03% 3.2¢ painchek ltd

As long as Painchek maintains the following quality, it is only...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,780 Posts.
    lightbulb Created with Sketch. 4485
    As long as Painchek maintains the following quality, it is only a matter of when, not if, the company will become a mini-Cochlear (over a billion dollar market cap) in the short term. Longer term (3-5 years), when Painfaces come to play, PCK could well challenge Cochlear for supremacy, given that it will have the same quality as Painchek as follows:

    a. Monopoly
    b. Necessary service
    c. Highly Scalable
    d. Philip Daffas

    Believe me, I may put PD as the last quality required, one could well put him on top too. At the end of the day, any products with qualities of a, b, and c will get nowhere without management quality like that of PD.

    For me, as long as those quality remains intact, I sleep well knowing my investment will grow each day I wake up. It is as simple as that.

    The above is just my thought for a Sunday morning
    Last edited by fattchoi: 03/11/19
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
-0.001(3.03%)
Mkt cap ! $52.39M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $1.155K 35.81K

Buyers (Bids)

No. Vol. Price($)
4 384560 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 79999 1
View Market Depth
Last trade - 14.19pm 05/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.